Inventor
JAYAKUMAR HONNAPPA
US17 patents
⚠️ This page may combine multiple inventors who share the name “JAYAKUMAR HONNAPPA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ARENA PHARM INC
10 patentsUS7884101B2Feb 8, 2011
3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC42 citations95
US9328107B2May 3, 2016
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC12 citations92
US9273035B2Mar 1, 2016
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
ARENA PHARM INC15 citations92
USRE45336EJan 13, 2015
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC12 citations92
USRE45337EJan 13, 2015
Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC11 citations92
US9221755B2Dec 29, 2015
Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC11 citations83
US9775829B2Oct 3, 2017
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
ARENA PHARM INC4 citations73
US9987252B2Jun 5, 2018
Primary amines and derivitves thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC1 citations62
US10781180B2Sep 22, 2020
3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC0 citations51
US10450276B2Oct 22, 2019
Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC0 citations51
TEEGARDEN BRADLEY
7 patentsUS8871797B2Oct 28, 2014
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
TEEGARDEN BRADLEY15 citations92
US8664258B2Mar 4, 2014
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
TEEGARDEN BRADLEY14 citations91
US8148418B2Apr 3, 2012
Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
TEEGARDEN BRADLEY16 citations91
US8148417B2Apr 3, 2012
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
TEEGARDEN BRADLEY21 citations91
US8754238B2Jun 17, 2014
Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
TEEGARDEN BRADLEY16 citations90
US8785441B2Jul 22, 2014
3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
TEEGARDEN BRADLEY11 citations82
US8680119B2Mar 25, 2014
Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
TEEGARDEN BRADLEY11 citations82